Pulmatrix, Inc.

US$1.38As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PULMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (40.62%)
Div yield —
ROE (98.35%)
Biotechnology
Beta (5Y) 1.92
PE TTM —
TSR TTM (72.01%)
Mkt cap US$5.040M
ROIC (62.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.38
(0.31%)
(60.60%)
Hold 1|11|3|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
0.33%
1.02%
3.93%
15.75%
Revenue$M
0.448
0.456
0.471
0.492
3.44%
4.83%
7.29%
8.11%
Peers (US$5.040M)
Cap (US$)
PE
4.878M
—
5.049M
6.626x
Capital
TTM
5Y
10Y
Leveragex
0.207
0.379
0.240
EBIT/Intx
1.655
0.135
0.175
Own earn%
154.31
76.41
56.66
Sh yield%
47.92
6.39
7.89
Owners
Insiders/Inst%
9.50
65.06
Short interest%
1.63
SBC / revenue%
1.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
17–23
$1 testx
0.0
Incr. ROIC%
2